3034:HK:HK-CSOP Metaverse Concept ETF (HKD)

ETF | Others |

Last Closing

USD 7.405

Change

-0.25 (-3.27)%

Market Cap

N/A

Volume

0.03M

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-04-09 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
2800:HK Tracker Fund of Hong Kong

+0.38 (+1.78%)

USD 159.33B
2833:HK Hang Seng Index Tracking Fund

N/A

USD 30.97B
2828:HK Hang Seng China Enterprises In..

+1.46 (+1.84%)

USD 30.56B
2801:HK iShares Core MSCI China ETF

+0.44 (+2.06%)

USD 22.44B
2823:HK iShares FTSE A50 China

+0.16 (+1.21%)

USD 17.65B
83188:HK ChinaAMC CSI 300 Index ETF

+0.24 (+0.62%)

USD 13.48B
9067:HK iShares Hang Seng TECH ETF

+0.04 (+3.44%)

USD 9.22B
3067:HK iShares Hang Seng TECH ETF

+0.20 (+1.99%)

USD 9.22B
82822:HK CSOP FTSE China A50

+0.07 (+0.60%)

USD 8.59B
9010:HK iShares Core MSCI AC Asia ex J..

+0.09 (+1.25%)

USD 3.03B

ETFs Containing 3034:HK

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -19.38% 21% F 24% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -19.38% 21% F 24% F
Trailing 12 Months  
Capital Gain -8.07% 42% F 49% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -8.07% 40% F 45% F
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain 8.69% 78% C+ 69% C-
Dividend Return 8.69% 77% C+ 66% D+
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 13.22% 75% C 91% A-
Risk Adjusted Return 65.75% 89% A- 93% A
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (HKD)

Quarterly Financials (HKD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

What to not like:

There is nothing we particularly dislike